Prostate Cancer News

Cancer drugs that received accelerated approval from the FDA gained regular approval significantly faster if their confirmatory trials demonstrated meaningful clinical benefits, according to results of a retrospective study.

Cancer mortality gradually declined over the past 2-plus decades, although the rate slowed between 2019 and 2022, according to results of the Annual Report to the Nation on the Status of Cancer.

Healthy lifestyle and dietary behaviors appeared associated with reduced all-cause and cardiovascular mortality among men with nonmetastatic prostate cancer, according to results of a prospective cohort study.

A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance intended to improve the design of randomized phase 3 trials.

Exercise improved erectile dysfunction compared with standard care among men with prostate cancer, according to study results published in JAMA Network Open.

NEW ORLEANS — In this video, Alan Dow, MD, MSHA, FACP, discusses evolving cancer screening guidelines and the controversies surrounding some of them.

Jonathan Kimmelman, PhD, has published multiple research papers and gotten into an inordinate number of debates about the clinical value of phase 1 trials.

In 2024, both Kate Middleton, Princess of Wales, and King Charles III told the world they had cancer.

Toxicity information from phase 3 oncology clinical trials often is incomplete and interpreted in ways that minimize its impact, according to findings published in JCO Oncology Practice.